Dermata Therapeutics, Inc. ( NASDAQ:DRMA – Get Rating ) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 30,600 shares, an increase of 155.0% from the March 15th total of 12,000 shares. Based on an average daily volume of 828,200 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.4% of the shares of the stock are sold short. Analysts Set New Price Targets Separately, Maxim Group lowered their price objective on shares of Dermata Therapeutics from $16.

https://www.dailypolitical.com/2023/04/16/short-interest-in-dermata-therapeutics-inc-nasdaqdrma-rises-by-155-0.html

#dailypolitical